GO Term | Evidence Code | PMID |
---|---|---|
protein autoprocessing | ||
activin receptor signaling pathway | ||
intracellular iron ion homeostasis | ||
multicellular organismal-level iron ion homeostasis | ||
negative regulation of transcription by RNA polymerase II |
GO Term | Evidence Code | PMID |
---|---|---|
cell surface | ||
HFE-transferrin receptor complex | ||
plasma membrane | ||
BMP receptor complex | ||
extracellular space |
GO Term | Evidence Code | PMID |
---|---|---|
BMP binding | ||
signaling receptor binding | ||
transferrin receptor binding | ||
coreceptor activity | ||
protein binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:8651 | Hodgkin's granuloma | |
DOID:8654 | Hodgkin's lymphoma, mixed cellularity | |
DOID:893 | Wilson disease | |
DOID:9351 | diabetes mellitus | |
DOID:9406 | hypopituitarism | |
DOID:9410 | panhypopituitarism | |
DOID:9452 | steatotic liver disease | |
DOID:9476 | Sheehan syndrome | |
DOID:9884 | muscular dystrophy | |
DOID:9970 | obesity |
HPO ID | HPO Term |
---|---|
HP:0000007 | Autosomal recessive inheritance |
HP:0000027 | Azoospermia |
HP:0000044 | Hypogonadotropic hypogonadism |
HP:0000135 | Hypogonadism |
HP:0000141 | Amenorrhea |
HP:0000789 | Infertility |
HP:0000802 | Impotence |
HP:0000819 | Diabetes mellitus |
HP:0000939 | Osteoporosis |
HP:0000953 | Hyperpigmentation of the skin |
Disease ID | Disease Name |
---|---|
ORPHA:79230 |
|
OMIM:602390 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
103224056 | CHLSB08474 | ||
108531364 | RHIBE32594 | ||
104671038 | RHIRO38134 | ||
100594831 | NOMLE04356 | ||
114587150 | PODMU28253 | ||
114592106 | PODMU06473 | ||
107592274 | SINGR14735 | ||
106847644 | EQUAS14956 | ||
115396931 | SALFA32040 | ||
105809638 | PROCO21728 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024